Mary L. Holtz

1.4k citations
17 papers · 724 indexed · h-index 10
Topics
Liver Disease Diagnosis and Treatment (4 papers)Neuroscience and Neuropharmacology Research (3 papers)Neuroinflammation and Neurodegeneration Mechanisms (3 papers)

In The Last Decade

Mary L. Holtz

16 papers receiving 711 citations

Peers

Mary L. Holtz
Comparison fields: 5 of 86
  • Molecular Biology 411
  • Epidemiology 237
  • Cellular and Molecular Neuroscience 129
  • Physiology 118
  • Hepatology 118
Replace Ji Won Park with:
Ji Won Park South Korea
Irina M. Zemtsova Germany
Khadija Iken United States
Yo Na Kim South Korea
Joost Daalhuisen Netherlands
Sheng Deng China
Yeonhee Cho United States
Gang Zuo China
Hao Qian China
Mary L. Holtz relative to Ji Won Park South Korea Ji Won Park's profile →
Citations per field
00.5×3.9×
Ji Won Park · 1×
Citations per year

Countries citing papers authored by Mary L. Holtz

Since Specialization
Citations

This map shows the geographic impact of Mary L. Holtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Holtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Holtz more than expected).

Fields of papers citing papers by Mary L. Holtz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. Holtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Holtz. The network helps show where Mary L. Holtz may publish in the future.

Co-authorship network of co-authors of Mary L. Holtz

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Holtz. A scholar is included among the top collaborators of Mary L. Holtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Holtz. Mary L. Holtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 226
5 1
6 92
7 5
8 18
9 11
10 5
11 16
12 6
13 50
14 58
15 103
16 10
17 115

About Mary L. Holtz

Mary L. Holtz is a scholar working on Hepatology, Neurology and Critical Care and Intensive Care Medicine, having authored 17 papers that have together received 724 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Hepatology (118 citations), Neurology (85 citations) and Developmental Neuroscience (40 citations). Mary L. Holtz has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include L. Creed Pettigrew, Susan D. Craddock, James W. Geddes, Stephen Minger, Mahin D. Maines, Nita H. Salzman, Nathan C. Hall, Andrew Fagan, Jasmohan S. Bajaj and Masoumeh Sikaroodi. Their work appears in journals such as Hepatology, Brain Research and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026